Plain-English translation of NCT06903325 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This trial is testing whether a new blood test called ColonAiQ — which looks for cancer DNA markers in your blood — can predict if your colorectal cancer will return after surgery. Researchers will compare patients whose blood tests are positive versus negative one month after surgery to see if this test helps predict who is at higher risk for cancer recurrence.
Currently, doctors don't have a good way to know which colorectal cancer patients are most likely to have their cancer come back after surgery. This new blood test could help identify high-risk patients early, so they can receive more intensive monitoring or treatment before cancer returns.
You likely qualify if…
You likely don't qualify if…
You will have blood samples taken before surgery, then again at 1 month after surgery, and every 3 months for up to 2 years. You'll also have standard follow-up visits with imaging scans (CT or MRI) and blood work every 3 months, following your hospital's normal care plan. If cancer recurrence is detected on imaging, one additional blood sample will be collected. In total, you'll be followed for at least 24 months after your surgery.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
China